Medicine and Healthcare

Topic overview

Coverage of medicine and healthcare, including clinical research, major disease treatments, drug approvals and safety, hospitals and health systems, public health developments, medical guidelines, and the business and policy decisions shaping patient care.

Recently curated for this topic.

Jul 10, 2026Gothamist

We mapped every UES cooling tower in the area affected by NYC’s latest Legionnaires’ outbreak

A map of Upper East Side cooling towers shows when each site was last inspected and when building owners last reported Legionella testing. The dataset is framed around the zone linked to New York City’s latest Legionnaires’ outbreak and flags gaps in timeliness across buildings. Cooling tower oversight is one of the few levers the city has to prevent airborne Legionella spread, and the compliance trail can quickly determine where public health action and liability concentrate.

Link to Story

Jul 10, 2026Bloomberg Markets

Bayer Sells $3.4 Billion Contraceptives Stake to Apollo

Bayer sold a minority stake in its contraceptives business to Apollo for €3 billion to raise cash. The proceeds will help fund costs tied to Roundup litigation. When litigation drives asset sales, it changes how the market values the company’s remaining portfolio and its ability to fund legal resolutions without diluting shareholders.

Link to Story

Jul 10, 2026ScienceDaily

This frog bacterium wiped out cancer tumors in mice with a single dose

Researchers report that a bacterium naturally found in amphibian intestines eliminated colorectal tumors in mice after a single treatment. The microbe appeared to both directly damage cancer cells and trigger an anti-tumor immune response, suggesting potential for broader solid-tumor therapy. It points to a new therapeutic class that could make durable, immune-mediated tumor clearance possible with simpler dosing, if safety and translation barriers can be cleared.

Link to Story

Jul 9, 2026ScienceDaily

A hidden immune backup system could supercharge mRNA cancer vaccines

New research reports that mRNA cancer vaccines can activate an unexpected immune cell type to prime strong anti-tumor responses, challenging the standard view of which cells drive vaccine-induced immunity. The finding points to ways to redesign mRNA cancer vaccines to improve effectiveness and personalize treatment. If vaccine potency depends on more than one immune entry point, mRNA cancer vaccines can be engineered to work in more patients and produce more reliable tumor control.

Link to Story

Jul 9, 2026Bloomberg Markets

Congo Ebola Responders Stay on Strike as Africa CDC Pushes to Resolve Pay Dispute

Africa CDC is pressing the Democratic Republic of Congo to accelerate overdue payments to Ebola responders after strikes in the outbreak’s epicenter disrupted containment operations. Officials describe the situation as the world’s fastest-growing Ebola outbreak, raising the stakes of any operational slowdown. Unpaid responders can turn a controllable outbreak into a regional emergency by breaking the human systems that stop transmission.

Link to Story

Jul 9, 2026Stat News

Outbreak of diarrhea-causing parasite grows to more than 1,000 cases

A U.S. outbreak of a diarrhea-causing parasite has surpassed 1,000 reported cases, making it one of the largest such events in years. Case counts indicate sustained transmission and a widening public health response. Large parasite outbreaks expose weaknesses in detection and prevention and can quickly translate into healthcare burden and public trust costs.

Link to Story

Join the Beta Now

Build Your First Pass.

Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!